INDEL therapeutics for the treatment of infectious disease.
INDEL therapeutics for the treatment of infectious disease.
批准号:
175247
负责人:
Reiner Neil E
金额:
$18.21万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2008
资助国家:
加拿大
项目状态:
已结题
起止时间:
2008-10-01 至 2009-10-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The INDEL platform was the recipient of a Proof of Principle I grant in 2004, which successfully validated the science and allowed the creation of a University of British Columbia start-up company, INDEL Therapeutics Inc. The platform technology enables
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Mechanisms of Leishmania Pathogenesis
-
批准号:388047
-
项目类别:Operating Grants
-
资助金额:$53.22万
-
财政年份:2018
-
负责人:Reiner Neil E
-
依托单位:
Novel Mechanisms of Leishmania Pathogenesis
-
批准号:265610
-
项目类别:Operating Grants
-
资助金额:$45.12万
-
财政年份:2012
-
负责人:Reiner Neil E
-
依托单位:
海外基金